BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) Study

NCT01708486 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2014-08-19

No results posted yet for this study

Summary

Patients' satisfaction with their asthma medication devices is usually decided by using properly designed questionnaires. These questionnaires are to be used to evaluate patients' opinion, which is considered very important for the selection of a device.

The Feeling of Satisfaction with Inhaler (FSI-10) is a self-completed questionnaire designed to assess the patient opinion regarding the satisfaction and usability of the inhalers irrespectively of the drug used. It consists of 10 question each with 5 possible responses on a 5-point Likert scale scored from 5 to 1, respectively. The total score can range between 10 and 50. The higher the score, the higher the feeling of patient satisfaction from the inhaler.

Conditions

Sponsors & Collaborators

  • Elpen Pharmaceutical Co. Inc.

    lead INDUSTRY

Principal Investigators

  • Ch Hatzimihael, MD Professor · Democretion University of Alexandroupolis, Pediatric Department, Thrace, Greece

  • Emm Paraskakis, MD, Ass Professor · Demokretion University of Alexandroupolis, Pediatric Department, Thrace, Greece

  • Ath Kaditis, MD · Agia Sofia Childrens Hospital of Athens, University Pediatric Clinic, Pulmonology Department

  • Poly Panayotopoulou, MD · Agia Sofia Childrens Hospital of Athens, University Pediatric Clinic, Pulmonology Department

  • Dimos Gidaris, MD Pulmonologist · Hippokration Hospital of Thessaloniki, Scientific collaborator

  • Michael Anthrakopoulos, MD, Associate Professor · University Hospital of Rio, Patras, Greece

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01708486 on ClinicalTrials.gov